Table 5 Treatment and Disease Severity between the Research Group and Control Group
From: Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children
| Characteristic, n (%) | Control group (n = 90) | Research group (n = 30) | P value |
|---|---|---|---|
| Fiberoptic bronchoscopy | 59 (65.6%) | 16 (53.3%) | 0.278 |
| Oxygen therapy | 58 (64%) | 28 (93%) | 0.001 |
| NCPAP | 0 | 5 (16.7%) | 0.01 |
| Invasive mechanical ventilation | 0 | 0 | – |
| PICU admission | 0 | 0 | – |
| Readmission | 9 (10%) | 3 (10%) | – |
| Severe CAP | 72 (80%) | 26 (87%) | 0.301 |
| Extremely severe pneumonia | 3 (3.3%) | 7 (23.3%) | 0.002 |
| Severe disease defined by clinical score system | 13 (14.4%) | 14 (46.6%) | 0.001 |